<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01938365</url>
  </required_header>
  <id_info>
    <org_study_id>CCEMD020</org_study_id>
    <nct_id>NCT01938365</nct_id>
  </id_info>
  <brief_title>Genetics of Type 1 Diabetes in Chinese Adolescents and Youth</brief_title>
  <official_title>A Prospective Cohort Study of Clinical Characteristics and Genetic Susceptibility of Type 1 Diabetes in Chinese Adolescents and Youth</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      primary outcome: To explore the genetic susceptibility of diabetes in Chinese adolescent and&#xD;
      youth.&#xD;
&#xD;
      secondary outcomes:&#xD;
&#xD;
        1. To classify diabetes by gene detection in Chinese adolescent and youth.&#xD;
&#xD;
        2. To make the relationship between genotype and clinic phenotype in type 1 diabetes.&#xD;
&#xD;
        3. To evaluate the effect of environmental factors (intestinal ecosystem)in the&#xD;
           pathogenesis of diabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Phase 1: Baseline investigation Aims: To explore genetic susceptibility of diabetes in&#xD;
      Chinese adolescent and youth.&#xD;
&#xD;
      Subjects and Methods: 500 patients under diabetic conditions and sex,age-matched NGR Healthy&#xD;
      control(2:1) will be enrolled ,all aged from 14-30 years old. A comprehensive examination&#xD;
      including questionnaire, anthropometric measurements, biochemical analysis will be performed&#xD;
      in each study participant. Diabetes should be diagnosed according to the WHO 1999&#xD;
      criteria,type 1 or type 2 diabetes diagnosed by clinical features recommended by&#xD;
      International Society of Pediatric and Adolescent Diabetes ( ISPAD ).&#xD;
&#xD;
      Phase 2: Cohort follow-up Aims : To explore the association of genetic backgrounds and&#xD;
      clinical characteristics in different types of diabetes in Chinese adolescent and youth.&#xD;
&#xD;
      Subjects and Methods: To recruit and follow up 200 newly diagnosed and genotyped patients for&#xD;
      3 years. Questionnaire, anthropometric measurements, biochemical analysis performed&#xD;
      respectively at baseline,3,6,12,24,36 months after enrollment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Deterioration of pancreatic islet function</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin dosage, HbA1c levels and evaluation of chronic complications</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Diabetes</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal glucose regulation</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood,fasting serum and stool&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        In phase 1:500 patients under diabetic conditions and sex,age-matched NGR(Normal glucose&#xD;
        regulation) (2:1) will be enrolled ,all aged from 14-30.&#xD;
&#xD;
        In phase 2:200 patients newly diagnosed diabetes (less than 6 month before enrollment )will&#xD;
        be genotyped and followed up for 3 years&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age: 14- 30 years old&#xD;
&#xD;
          2. Gender: males and females&#xD;
&#xD;
          3. Race: han&#xD;
&#xD;
          4. Diabetes diagnosed by WHO cafeteria (WHO1999)&#xD;
&#xD;
          5. Living in east China area to minimize population stratification&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Secondary diabetes caused by other diseases or drugs&#xD;
&#xD;
          2. Moderate to severe liver, kidney dysfunction, i.e. ALT/AST &gt; 2.5 times the upper limit&#xD;
             of normal range or Ccr &lt; 25ml/min;&#xD;
&#xD;
          3. Any other condition or major systemic diseases that the investigator feels would&#xD;
             interfere with trial participation or evaluation of results.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ruijin hospital, Shanghai Jiao-Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guang Ning, Professor</last_name>
      <phone>8621-64370045</phone>
      <phone_ext>665344</phone_ext>
      <email>feifei1116@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Guang Ning, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <study_first_submitted>September 4, 2013</study_first_submitted>
  <study_first_submitted_qc>September 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2013</study_first_posted>
  <last_update_submitted>November 11, 2013</last_update_submitted>
  <last_update_submitted_qc>November 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Guang Ning</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

